Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
María M. Caffarel(Universidad Complutense de Madrid), Cristina Sánchez(Universidad Complutense de Madrid)
Cited by 193
Related Papers
Therapeutic targeting of HER2–CB <sub>2</sub> R heteromers in HER2-positive breast cancer
|Proceedings of the National Academy of Sciences|2019|62